TOMI Environmental Solutions, Inc. (TOMZ) - Annual Investor Guide

I have reviewed the latest annual report for TOMI Environmental Solutions. The company reported $7.2 million in revenue for 2025, compared to $8.1 million in 2024. As they navigate this transition, here is the current situation.

1. What do they do?

TOMI produces specialized disinfection equipment under the SteraMist brand. Their technology utilizes ionized Hydrogen Peroxide to eliminate 99.9999% of pathogens, including bacteria and viruses, without leaving toxic residue.

Their business model consists of two primary revenue streams: equipment sales and the sale of proprietary "BIT Solution" refills. In 2025, recurring sales and service contracts accounted for approximately 45% of total revenue, providing a foundation for more predictable income compared to one-time equipment sales.

2. Major Wins & Strategy

TOMI is currently prioritizing the integration of SteraMist technology into permanent facility infrastructure:

• The "Engine" Strategy: The company is shifting focus from portable units to partnerships with equipment manufacturers. By integrating SteraMist into cleanroom enclosures produced by partners like ESCO and Getinge, TOMI secures a long-term role within these facilities.
• The Pipeline: There are 10 active integration projects currently in progress. These represent approximately $3 million in potential contract value, expected to be realized over the next 18 to 24 months.
• Food Safety: Following FDA clearance for use on food, TOMI is targeting the food processing industry. They are currently conducting pilot programs to decontaminate items such as cheese and strawberries.
• Client Base: Their portfolio includes high-profile organizations such as NASA, Pfizer, and Merck, which serves to validate the efficacy of their technology.

3. Financial Health & Risks

• Liquidity: TOMI ended 2025 with approximately $1.8 million in cash. To support operations, they have established an equity line of credit allowing for the sale of up to $20 million in stock. Investors should note that utilizing this facility will result in shareholder dilution.
• Profitability: The company reported a loss of $5.4 million in 2025. Because they lack long-term service contracts with guaranteed minimums, revenue remains variable, which complicates cash flow forecasting.
• Reporting Standards: The company has identified "material weaknesses" in their financial reporting, which has created challenges regarding Nasdaq compliance. Management is currently working to address these internal control issues.

4. Future Outlook

Management is focused on stabilizing revenue through integrated systems that drive steady demand for BIT Solution refills. They are also exploring niche applications, including the decontamination of firefighter gear and the protection of commercial bee hives. The company’s success is tied to its ability to scale these partnerships and achieve consistent revenue growth.

The Bottom Line

TOMI is a "show-me" story. While they possess proprietary technology and a prestigious client list, they are currently operating at a cash deficit. The coming year serves as a critical test of their ability to successfully transition to a recurring-revenue model, reduce losses, and execute their partnership strategy. When evaluating this opportunity, consider whether you believe their integration strategy will generate the consistent cash flow necessary to move the company toward profitability.